Cite
HARVARD Citation
Bussel, J. et al. (n.d.). Fostamatinib for the treatment of adult persistent and chronic immune thrombocytopenia: Results of two phase 3, randomized, placebo‐controlled trials. American journal of hematology. 93 (7), pp. 921-930. [Online].